The PyMT model is characterized by low-grade antitumor inflammation, such as a poor response to anti-programmed cell death protein-1 (PD-1) immune checkpoint blockade.24 25 Thus, only strong modulators of tumor immunity affect tumor growth in this model. This evidence concerns the gene PDCD1 and neoplasm.